Analysis of immune response patterns in naïve and Plasmodium berghei-infected young rats following a ferroquine treatment

International Journal for Parasitology

Volumn 35, Issue 14, 2005, Pages 1601-1610

  Pierrot, Christine ^a   Lafitte, Sophia ^a   Dive, Daniel ^a   Fraisse, Laurent ^b   Brocard, Jacques ^c   Khalife, Jamal ^a  

^a INSERM   (France)

^b SANOFI   (France)

^c Ecole Nationale Superieure de Chimie de Lille   (France)

Author keywords

Chloroquine; Ferroquine; Immune response; Malaria; Plasmodium berghei; Rat

Indexed keywords

ANTIMALARIAL AGENT; FERROQUINE; SSR 97193; UNCLASSIFIED DRUG;

IMMUNE RESPONSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALARIA; NONHUMAN; PARASITE; PARASITEMIA; PLASMODIUM FALCIPARUM; RAT;

AMINOQUINOLINES; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; CELL PROLIFERATION; CELLS, CULTURED; CHLOROQUINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERROUS COMPOUNDS; FLOW CYTOMETRY; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; MALARIA; PLASMODIUM BERGHEI; RATS; RATS, INBRED F344; SPLEEN;

ANIMALIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 28244481438     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2005.07.007     Document Type: Article

References (40)

1. E. Adam, C. Pierrot, S. Lafitte, C. Godin, A. Saoudi, M. Capron, and J. Khalife The age-related resistance of rats to Plasmodium berghei infection is associated with differential cellular and humoral immune responses Int. J. Parasitol. 33 2003 1067 1078
2. A.A. Asindi, E.E. Ekanem, E.O. Ibia, and M.A. Nwangwa Upsurge of malaria-related convulsions in a paediatric emergency room in Nigeria. Consequence of emergence of chloroquine-resistant Plasmodium falciparum Trop. Geogr. Med. 45 1993 110 113
3. C. Atteke, J.M. Ndong, A. Aubouy, L. Maciejewski, J. Brocard, J. Lebibi, and P. Deloron In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooue region of Gabon J. Antimicrob. Chemother. 51 2003 1021 1024
4. C. Biot, G. Glorian, L.A. Maciejewski, and J.S. Brocard Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue J. Med. Chem. 40 1997 3715 3718
5. C. Biot, L. Delhaes, H. Abessolo, O. Domarle, L.A. Maciejewski, M. Mortuaire, P. Delcourt, P. Deloron, D. Camus, D. Dive, and J.S. Brocard Novel metallocenic compounds as antimalarial agents. Study of the position of ferrocene in chloroquine J. Organomet. Chem. 589 1999 59 65
6. C. Biot, L. Delhaes, C.M. N'Diaye, L.A. Maciejewski, D. Camus, D. Dive, and J.S. Brocard Synthesis and antimalarial activity in vitro of potential metabolites of ferrochloroquine and related compounds Bioorg. Med. Chem. 7 1999 2843 2847
7. B.A. Bottger, M. Sjolund, and J. Thyberg Chloroquine and monensin inhibit induction of DNA synthesis in rat arterial smooth muscle cells stimulated with platelet-derived growth factor Cell Tissue Res. 252 1988 275 285
8. H. Broll Effect of chloroquine diphosphate on the superhelix structure of DNA and protein synthesis in synovial cells in chronic polyarthritis Wien. Klin. Wochenschr. 95 1983 877 880
9. I.C. Bygbjerg, and H. Flachs Effect of chloroquine on human lymphocyte proliferation Trans. R. Soc. Trop. Med. Hyg. 80 1986 231 235
10. P. Chim, P. Lim, R. Sem, S. Nhem, L. Maciejewski, and T. Fandeur The in-vitro antimalarial activity of ferrochloroquine, measured against Cambodian isolates of Plasmodium falciparum Ann. Trop. Med. Parasitol. 98 2004 419 424
11. H.I. Daniel, and N.B. Molta Efficacy of chloroquine in the treatment of malaria in children under five years in Baissa (Gongola State, Nigeria) Ann. Trop. Med. Parasitol. 83 1989 331 338
12. L. Delhaes, H. Abessolo, C. Biot, L. Berry, P. Delcourt, L. Maciejewski, J. Brocard, D. Camus, and D. Dive In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites Parasitol. Res. 87 2001 239 244
13. L. Delhaes, C. Biot, L. Berry, P. Delcourt, L.A. Maciejewski, D. Camus, J.S. Brocard, and D. Dive Synthesis of ferroquine enantiomers: first investigation of effects of metallocenic chirality upon antimalarial activity and cytotoxicity Chembiochem 3 2002 418 423
14. O. Domarle, G. Blampain, H. Agnaniet, T. Nzadiyabi, J. Lebibi, J. Brocard, L. Maciejewski, C. Biot, A.J. Georges, and P. Millet In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine Antimicrob. Agents Chemother. 42 1998 540 544
15. S.I. Hay, C.A. Guerra, A.J. Tatem, A.M. Noor, and R.W. Snow The global distribution and population at risk of malaria: past, present, and future Lancet Infect. Dis. 4 2004 327 336
16. H. Hisaeda, Y. Maekawa, D. Iwakawa, H. Okada, K. Himeno, K. Kishihara, S. Tsukumo, and K. Yasutomo Escape of malaria parasites from host immunity requires CD4(+)CD25(+) regulatory T cells Nat. Med. 10 2004 29 30
17. J.Y. Jeong, and D.M. Jue Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages J. Immunol. 158 1997 4901 4907
18. H. Kalisz, G. Pohlig, and H. Holzer Inhibition of protein phosphorylation by chloroquine Arch. Microbiol. 147 1987 235 239
19. I. Karres, J.P. Kremer, I. Dietl, U. Steckholzer, M. Jochum, and W. Ertel Chloroquine inhibits proinflammatory cytokine release into human whole blood Am. J. Physiol. 274 1998 R1058 R1064
20. C.O. Khoromana, C.C. Campbell, J.J. Wirima, and D.L. Heymann In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age Am. J. Trop. Med. Hyg. 35 1986 465 471
21. R. Kovjazin, T. Eldar, M. Patya, A. Vanichkin, H.M. Lander, and A. Novogrodsky Ferrocene-induced lymphocyte activation and anti-tumor activity is mediated by redox-sensitive signaling FASEB J. 17 2003 467 469
22. F. Kwakye-Berko, and S.R. Meshnick Binding of chloroquine to DNA Mol. Biochem. Parasitol. 35 1989 51 55
23. R.B. Landewe, A.M. Miltenburg, M.J. Verdonk, C.L. Verweij, F.C. Breedveld, M.R. Daha, and B.A. Dijkmans Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness Clin. Exp. Immunol. 102 1995 144 151
24. L. Lege-Oguntoye, G.C. Onyemelukwe, B.B. Maiha, E.O. Udezue, and S. Eckerbom The effect of short-term malaria chemoprophylaxis on the immune response of semi-immune adult volunteers East Afr. Med. J. 67 1990 770 778
25. T.T. Long, S. Nakazawa, S. Onizuka, M.C. Huaman, and H. Kanbara Influence of CD4(+)CD25(+) T cells on Plasmodium berghei NK65 infection in BALB/c mice Int. J. Parasitol. 33 2003 175 183
26. W.I. Olanrewaju, and A.W. Johnson Chloroquine-resistant Plasmodium falciparum malaria in Ilorin, Nigeria: prevalence and risk factors for treatment failure Afr. J. Med. Med. Sci. 30 2001 165 169
27. L.M. Osorio, L. Fonte, and C.M. Finlay Inhibition of human monocyte function by prophylactic doses of chloroquine Am. J. Trop. Med. Hyg. 46 1992 165 168
28. S. Picot, F. Peyron, J.P. Vuillez, B. Polack, and P. Ambroise-Thomas Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro J. Infect. Dis. 164 1991 830
29. C. Pierrot, E. Adam, S. Lafitte, C. Godin, D. Dive, M. Capron, and J. Khalife Age-related susceptibility and resistance to Plasmodium berghei in mice and rats Exp. Parasitol. 104 2003 81 85
30. B. Pradines, T. Fusai, W. Daries, V. Laloge, C. Rogier, P. Millet, E. Panconi, M. Kombila, and D. Parzy Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum J. Antimicrob. Chemother. 48 2001 179 184
31. B. Pradines, A. Tall, C. Rogier, A. Spiegel, J. Mosnier, L. Marrama, T. Fusai, P. Millet, E. Panconi, J.F. Trape, and D. Parzy In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs Trop. Med. Int. Health. 7 2002 265 270
32. R. Rosa, H. Silveira, E. Seixas, N. Rolao, G. Santos-Gomes, and V. do Rosario The effect of chloroquine on the production of interferon-gamma, interleukin (IL)-4, IL-6, and IL-10 in Plasmodium chabaudi chabaudi in infected C57BL6 mice J. Parasitol. 85 1999 956 960
33. G. Salmeron, and P.E. Lipsky Immunosuppressive potential of antimalarials Am. J. Med. 75 1983 19 24
34. A.F. Tawfik, S.J. Bishop, A. Ayalp, and F.S. el-Feraly Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice Int. J. Immunopharmacol. 12 1990 385 389
35. T.G. Theander, I.C. Bygbjerg, B.J. Andersen, S. Jepsen, A. Kharazmi, and N. Odum Suppression of parasite-specific response in Plasmodium falciparum malaria. A longitudinal study of blood mononuclear cell proliferation and subset composition Scand. J. Immunol. 24 1986 73 81
36. B.E. van den Borne, B.A. Dijkmans, H.H. de Rooij, S. le Cessie, and C.L. Verweij Chloroquine and hydroxychloroquine equally affect tumor necrosis factor- alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells J. Rheumatol. 24 1997 55 60
37. W.P. Weidanz Malaria and alterations in immune reactivity Br. Med. Bull. 38 1982 167 172
38. J. Wiesner, R. Ortmann, H. Jomaa, and M. Schlitzer New antimalarial drugs Angew. Chem. Int. Ed. Engl. 42 2003 5274 5293
39. S.X. Yang, S.S. Xie, H.L. Gao, and Z.Z. Long Artemisinin and its derivatives enhance T lymphocyte-mediated immune responses in normal mice and accelerate immunoreconstitution of mice with syngeneic bone marrow transplantation Clin. Immunol. Immunopathol. 69 1993 143 148
40. J.R. Zucker, E.M. Lackritz, T.K. Ruebush 2nd, A.W. Hightower, J.E. Adungosi, J.B. Were, B. Metchock, E. Patrick, and C.C. Campbell Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens Am. J. Trop. Med. Hyg. 55 1996 655 660